D-0134-2017 Class III Terminated
FDA drug recall D-0134-2017 was initiated by Taro Pharmaceuticals U.S.A., Inc. on May 26, 2016 and is designated Class III. Reason for recall: Subpotent Drug: Out of Specification assay values on stability for the active ingredient, zinc pyrithione. The recall status is terminated (terminated Jun 6, 2018). Affected quantity: 17,100 kits.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 16, 2016
- Initiation Date
- May 26, 2016
- Termination Date
- Jun 6, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17,100 kits
Product description
Kamedis BIO-HERBAL DANDRUFF CARE THERAPEUTIC 2-STEP DANDRUFF CARE SYSTEM - Kamedis Bio-Herbal Dandruff Care 0.1% PYRITHIONE ZINC, STEP 1 PRE-TREAT Concentrated Botanical Scalp Lotion (0.1% Pyrithione Zinc) 4.20 FL OZ (125mL) (NDC 51672-2126-0) and STEP 2 CLEANSE Concentrated Botanical Dandruff Shampoo (1.0% Pyrithione Zinc)(0.6.80 FL OZ (200 mL) (NDC 51672-2125-5), Distributed by: Taro Pharmaceuticals U.S.A, Inc. Hawthorne, NY 10532. NDC
Reason for recall
Subpotent Drug: Out of Specification assay values on stability for the active ingredient, zinc pyrithione.
Distribution pattern
Nationwide
Code information
Lot #: E601, E602, E603, E604, E608, E609 - Exp. September 2017; E610 E611, Exp. October 2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0134-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026